These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28147442)

  • 21. Hyperspectral imaging signatures detect amyloidopathy in Alzheimer's mouse retina well before onset of cognitive decline.
    More SS; Vince R
    ACS Chem Neurosci; 2015 Feb; 6(2):306-15. PubMed ID: 25354367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligomeric α-synuclein and β-amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases.
    Williams SM; Schulz P; Sierks MR
    Eur J Neurosci; 2016 Jan; 43(1):3-16. PubMed ID: 26332448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cataract, Alzheimer's disease, and other conformational diseases.
    Harding JJ
    Curr Opin Ophthalmol; 1998 Feb; 9(1):10-3. PubMed ID: 10178625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing.
    Rowe CC; Bourgeat P; Ellis KA; Brown B; Lim YY; Mulligan R; Jones G; Maruff P; Woodward M; Price R; Robins P; Tochon-Danguy H; O'Keefe G; Pike KE; Yates P; Szoeke C; Salvado O; Macaulay SL; O'Meara T; Head R; Cobiac L; Savage G; Martins R; Masters CL; Ames D; Villemagne VL
    Ann Neurol; 2013 Dec; 74(6):905-13. PubMed ID: 24448836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of biomarkers in clinical trials for Alzheimer disease.
    Thal LJ; Kantarci K; Reiman EM; Klunk WE; Weiner MW; Zetterberg H; Galasko D; Praticò D; Griffin S; Schenk D; Siemers E
    Alzheimer Dis Assoc Disord; 2006; 20(1):6-15. PubMed ID: 16493230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clearing the amyloid in Alzheimer's: progress towards earlier diagnosis and effective treatments - an update for clinicians.
    Asih PR; Chatterjee P; Verdile G; Gupta VB; Trengove RD; Martins RN
    Neurodegener Dis Manag; 2014; 4(5):363-78. PubMed ID: 25405650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New biomarkers and drug targets for diagnosis and therapy of Alzheimer's disease (molecular determinants of zinc-dependent oligomerization of Β-amyloid)].
    Kozin SA; Makarov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):5-9. PubMed ID: 25909782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biomarkers for early diagnosis of Alzheimer's disease].
    Frederiksen KS; Hasselbalch S; Law I; Højgaard L; Waldemar G
    Ugeskr Laeger; 2015 Jun; 177(24):. PubMed ID: 26058526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
    Prvulovic D; Hampel H
    Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alzheimer's disease.
    Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
    Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative aspects of glucose catabolism by rainbow and lake trout ocular tissues including alterations resulting from various pathological conditions.
    Hoffert JR; Fromm PO
    Exp Eye Res; 1970 Oct; 10(2):263-72. PubMed ID: 5484769
    [No Abstract]   [Full Text] [Related]  

  • 32. Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease.
    Catania M; Di Fede G; Tonoli E; Benussi L; Pasquali C; Giaccone G; Maderna E; Ghidoni R; Tagliavini F
    J Alzheimers Dis; 2015; 47(4):877-81. PubMed ID: 26401767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular biomarkers for early detection of Alzheimer's disease.
    Frost S; Martins RN; Kanagasingam Y
    J Alzheimers Dis; 2010; 22(1):1-16. PubMed ID: 20847434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinal biomarkers provide "insight" into cortical pharmacology and disease.
    Nguyen CTO; Hui F; Charng J; Velaedan S; van Koeverden AK; Lim JKH; He Z; Wong VHY; Vingrys AJ; Bui BV; Ivarsson M
    Pharmacol Ther; 2017 Jul; 175():151-177. PubMed ID: 28174096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ocular anomalies in a cystinosis animal model mimic disease pathogenesis.
    Kalatzis V; Serratrice N; Hippert C; Payet O; Arndt C; Cazevieille C; Maurice T; Hamel C; Malecaze F; Antignac C; Müller A; Kremer EJ
    Pediatr Res; 2007 Aug; 62(2):156-62. PubMed ID: 17597652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current state and future directions of neurochemical biomarkers for Alzheimer's disease.
    de Jong D; Kremer BP; Olde Rikkert MG; Verbeek MM
    Clin Chem Lab Med; 2007; 45(11):1421-34. PubMed ID: 17970699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid-β - a reflection of risk or a preclinical marker?
    Jack CR; Vemuri P
    Nat Rev Neurol; 2018 Jun; 14(6):319-320. PubMed ID: 29713016
    [No Abstract]   [Full Text] [Related]  

  • 39. Alzheimer disease therapy: can the amyloid cascade be halted?
    Golde TE
    J Clin Invest; 2003 Jan; 111(1):11-8. PubMed ID: 12511580
    [No Abstract]   [Full Text] [Related]  

  • 40. Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-β.
    Maya Y; Okumura Y; Kobayashi R; Onishi T; Shoyama Y; Barret O; Alagille D; Jennings D; Marek K; Seibyl J; Tamagnan G; Tanaka A; Shirakami Y
    Brain; 2016 Jan; 139(Pt 1):193-203. PubMed ID: 26490333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.